Sanofi said it entered talks to sell a controlling stake in consumer health business Opella to private-equity firm Clayton ...

Injectable drug delivery systems are becoming increasingly popular as healthcare professionals seek better ways to treat life ...

The global pneumococcal vaccines market is poised for significant growth, with projections indicating a Compound Annual ...

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...

ShareUK pharmaceutical giant, GSK said it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

GSK shares rose after the British drug major agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer. Write to Rob ...

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...

Global Pediatric Influenza Treatment MarketThe global pediatric influenza treatment market is set to experience steady growth over the next decade, with market size expected to rise from USD 578.2 ...

UK stocks saw mixed performances as dividend exclusions weighed on some major companies, while GSK shares surged post-lawsuit ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

The FTSE 100 index closed down 6.01 points, 0.1%, at 8,237.73. The FTSE 250 ended 114.01 points lower, 0.6%, at 20,708.37, and the AIM All-Share fell 2.13 points, 0.3%, to 734.53.